Hookipa Pharma Inc.

13F holders, Q3 2024 (September 30)
1holders −38
0new positions
15sold out
$13.03avg. 13F price*

At the end of Q3 2024, 1 institutions reported holding Hookipa Pharma Inc. in their 13F filings, down 38 from Q2 2024. 0 opened new positions and 15 sold out. The largest holder was Knoll Capital Management, LLC ($7.2M).

Company
Hookipa Pharma Inc.
CUSIP
43906K100
Latest filing quarter
Q3 2025

History

Number of 13F holders

01020304050 Q1 2024: 47Q1 2024Q2 2024: 39Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 1Q1 2025Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions0$0
Exits15$3.6M

All 13F filers, Q2 2024 → Q3 2024: 11,122,089 shares sold, net −11,122,089 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

Knoll Capital Management, LLC 3.33% Reduce -90.0% 551,738 $7.2M

"% of holder's portfolio" is HOOKIPA PHARMA INC's weight in each manager's 13F, not the share of Hookipa Pharma Inc. the manager owns.